Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.71
0.13 (1.72%)
At close: Aug 15, 2025, 3:07 PM

Cullinan Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
83M 98.43M 156.15M 59.77M
Short-Term Investments
315.97M 368.63M 311.14M 230.69M
Long-Term Investments
204.44M n/a 80.88M 140.4M
Other Long-Term Assets
366K 459K 459K 147K
Receivables
3M 5.4M n/a n/a
Inventory
n/a -5.4M n/a n/a
Other Current Assets
12.69M n/a n/a n/a
Total Current Assets
414.67M 480.19M 474.47M 296.56M
Property-Plant & Equipment
2.35M 3.53M 5.3M 77K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
207.16M 3.99M 86.64M 140.62M
Total Assets
621.82M 484.18M 561.12M 437.19M
Account Payables
1.68M 2.49M 2.66M 3.17M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.3M 1.44M 178K n/a
Other Current Liabilities
135K 15.78M 1.96M 973K
Total Current Liabilities
30.65M 28.14M 22.5M 11.75M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 65K
Total Long-Term Liabilities
849K 2.15M 3.59M 65K
Total Liabilities
31.5M 30.29M 26.09M 11.81M
Total Debt
2.15M 3.59M 5.19M n/a
Common Stock
6K 4K 5K 4K
Retained Earnings
-368.24M -200.86M -47.7M -158.91M
Comprehensive Income
-133K -129K -2.6M -838K
Shareholders Equity
590.33M 453.7M 535.03M 424.97M
Total Investments
520.41M 368.63M 392.02M 371.09M